Yawning and Stretching Induced by Transcranial Application of AC Pulsed Electromagnetic Fields in Parkinson's Disease

References

• Anias J., Holmgren B., Urba Holmgren R., Eguibar J. R. Circadian variation of yawning behavior. Acda Neurohiologica Experimentale (Warsz) 1984; 44: 179–186
   PubMedGoogle Scholar
• Argiolas A., Melis M. R. The neuropharmacology of yawning. European Journal of Pharmacology 1998; 343: 1–16
   PubMed Web of Science ®Google Scholar
• Baenninger R., Binkley S., Baenninger M. Field observations of yawning and activity in humans. Physiology & Behavior 1996; 59: 421–425
   PubMedGoogle Scholar
• Bertolini A., Gessa G. L. Behavioral effects of ACTH and MSH peptides. Journal of Endocrine Investigation 1981; 4: 241–251
   PubMed Web of Science ®Google Scholar
• Boshes B. Syndromes of the diencephalon. Handbook of clinical neurology: Localization in clinical neurology, J. P. Vinken, G. W. Bruyn. Elsevier, Amsterdam 1969; Vol, 2: 450
   Google Scholar
• Coneu A., Ferrari W., Gessa G. L., Mereu G. P., Tagliamome A. LFG changes induced by the intraventricular injection of ACTH in cats. Sleep, P. Levin, W. P. Koella. Karger., Basel 1974; 321
   Google Scholar
• Cooper S. J., Rusk I. N., Barber D. J. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine auioreceptor antagonist (-)-UH 232. Physiology & Behavior 1989; 45: 1263–1266
   PubMed Web of Science ®Google Scholar
• Dejong R. N. The neurology examination. Harper & Row., Philadelphia 1979; 237
   Google Scholar
• D'Mello D. A., Vincent F. M., Lerner M. P. Yawning as a complication of electroconvulsive therapy and concurrent neuroleptic withdrawal. Journal of Nervous and Mental Disease 1988; 176: 188–189
   PubMedGoogle Scholar
• Dourish C. T., Cooper S. J. Behavioral evidence for the existence of dopamine auloreeeptors. Trends in Pharmacological Sciences 1985; 6: 17–24
   Google Scholar
• Ferrari W. Behavioral changes in animals after intracisternal injeclion with adrenocorlicolrophic hormone and melanoeyte stimulating hormone. Nature 1958; 181: 925–926
   PubMedGoogle Scholar
• Ferrari W., Gessa G. L., Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSFI. Annals of the New York Academy of Sciences 1963; 104: 330–345
   PubMed Web of Science ®Google Scholar
• Floris F. Effects of intraspinal injection of ACTH in man. Bulletin of the Society of ltalien Biology 1963; 39: 558–560
   PubMedGoogle Scholar
• Gershanik O., Heikkila R. F., Duvoisin R. C. Behavioral correlations of dopamine receptor activation. Neurology 1983; 33: 1489–1492
   PubMed Web of Science ®Google Scholar
• Gessa G. L., Pisano M., Vargiu L., Carbai F., Ferrari W. Stretching and yawning movements after intracerebral injection of ACTFI. Revue Canadienne Biologique 1967; 26: 229–236
   PubMedGoogle Scholar
• Goren J. L., Friedman J. H. Yawning as an aura for an L-dopa-induced “on” in Parkinson's disease. Neurology 1998; 50: 823
   PubMedGoogle Scholar
• Lehmann H. E. Yawning: a homeostatic reflex and its psychological significanee. Bulletin of the Menninger Clinic 1979; 43: 123–136
   PubMed Web of Science ®Google Scholar
• Longoni R., Spina L., Di Chiara G. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of poslsynaptic D-2 mediated behavioral responses. European Journal of Pharmacology 1987; 134: 163–173
   PubMedGoogle Scholar
• Mogilnicka F., Kilmek V. Drugs affeeting dopamine neurones and yawning behaviour. Pharmacology Biochemistry and Behavior 1977; 7: 303–305
   PubMed Web of Science ®Google Scholar
• Mora S., Diaz-Veliz G. LHRH antagonizes yawning and genital grooming induced by apomorphine in rats. Pharmacology Biochemistry & Behavior 1989; 31: 717–720
   Google Scholar
• Reynolds G. P., Riederer P. The ncuropharmacology of Parkinson's disease. Parkinson's disease, G. Stern. Chapman and Hall Medical., London 1990; 127–149
   Google Scholar
• Rollinson R. D., Wiggins W. S., Gilligan B. S. Drug-induced yawning successfully Heated with pimozide. Archives of Neurology 1979; 36: 253
   Google Scholar
• Sandyk R. Cholinergic mechanisms in Gilles de la Tourette's syndrome. International Journal of Neuroseienc 1995; 81: 95–100
   PubMedGoogle Scholar
• Sandyk R. The biological significance of yawning elicited by application of electromagnetic fields in multiple sclerosis. Internalional Journal of Neuroscience 1997; 89: 53–60
   PubMed Web of Science ®Google Scholar
• Schachter M., Bedard P., Debono A. G., Jenner P., Marsden C. D., Rosenthaler J., Horowski R., Dorow R. The role of D-l and D-2 receptors. Nature 1981; 286: 157–159
   Web of Science ®Google Scholar
• Serra G., Collu M., Gessa G. L. Dopamine receptors mediating yawning: are they autoreceptors. European Journal of Pharmacology 1986; 120: 187–192
   PubMed Web of Science ®Google Scholar
• Serra G., Collu M., Gessa G. L. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390. Psychopharmacology 1987; 91: 330–333
   PubMed Web of Science ®Google Scholar
• Stahle L., Ungerstedt U. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+) 3-PPP, and (-) 3-PPP by recording of yawning behavior in rats. European Journal of Pharmacology 1984; 98: 307–310
   PubMedGoogle Scholar
• Szechtman H., Cleghorn J. M., Brown G. M., Kaplan R. D., Franco S., Rosenthal K. Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea and hyperthermia. Psychiatry Research 1988; 23: 245–255
   PubMed Web of Science ®Google Scholar
• Urba-Holmgren R., Holmgren B., Rodriguez R., Gonzalez R. M. Serotonergic modulation of yawning. Pharmacology Biochemistry & Behavior 1979; 11: 371–372
   PubMedGoogle Scholar
• Yamada K., Furukawa T. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation of yawning. Psychopharmacology 1980; 67: 39–43
   PubMed Web of Science ®Google Scholar
• Zarrindast M. R., Toloui V., Hashemi B. Effect of GABA-ergic drugs on physostigmine-induced yawning in rats. Psychopharmacology (Berlin) 1995a; 122: 297–300
   PubMedGoogle Scholar
• Zarrindast M. R., Fatehi F., Mohagheghi-Badi M. Effects of adenosine agents on apomorphine-induced yawning in rats. Psychopharmacology 1995b; 122: 292–296
   PubMedGoogle Scholar